SLF is a synthetic FKBP ligand that binds FKBP-family immunophilins and is widely used as a modular recognition element in chemically induced proximity systems. Its compact structure and defined FKBP-binding mode make it suitable for incorporation into PROTAC-like molecules, molecular glues, and degrader constructs that use FKBP recognition as a controllable protein-binding handle. In a targeted degradation design, SLF can be attached to a linker and an E3 ligase recruiter to position FKBP or FKBP-fusion proteins near ubiquitination machinery. The intended mechanism is ligand-directed proximity, ubiquitination of the recruited protein, and proteasome-dependent depletion when a productive complex is formed. SLF is useful for FKBP12 degradation studies, fusion-protein degrader models, induced-proximity platform development, linker exit-vector evaluation, and chemical biology workflows requiring selective recruitment of engineered or endogenous immunophilin-associated proteins.
Structure of 195513-96-3
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 100 mg | $799 | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Target: This ligand targets FK506-binding protein FKBP12 in biochemical or cellular target-engagement studies.
Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for FK506-binding protein FKBP12. In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings FK506-binding protein FKBP12 into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.
Applications• SLF-Based PROTAC Development: SLF can be used as a targeting ligand within PROTAC architectures to engage a chosen E3 ligase and recruit the target protein for ubiquitination. This enables systematic testing of linker length, attachment chemistry, and ternary-complex stabilization to drive efficient proteasome-dependent degradation in cellular models.
• Target Protein Degradation Profiling: Incorporate SLF into PROTAC constructs to evaluate degradation kinetics and dose–response behavior of the intended protein. Researchers can quantify loss of target abundance, monitor recovery after washout, and compare degradation versus inhibition to identify whether SLF-driven engagement produces sustained, mechanism-based protein turnover.
• E3 Ligase Recruitment Optimization: Use SLF as a modular component to optimize E3 ligase recruitment strength and specificity in targeted protein degradation. By varying SLF conjugation sites and linker properties, investigators can tune ternary-complex formation, reduce off-target ubiquitination, and improve degradation selectivity across related protein family members.
• Mechanistic Studies of Ubiquitination: SLF-containing PROTACs support mechanistic interrogation of ubiquitin transfer and proteasome dependence. Experiments such as ubiquitination assays, proteasome inhibition, and competition with pathway ligands can clarify whether SLF-mediated recruitment effectively drives ubiquitin chain formation and productive commitment to degradation.
• Proteome-Wide Degradation Mapping: Apply SLF-based PROTACs to study broader degradation outcomes using proteomics workflows. Quantitative mass spectrometry can reveal on-target degradation efficiency, identify unexpected off-targets, and correlate degradation signatures with SLF-driven binding features, guiding iterative PROTAC redesign for improved selectivity and potency.
SLF is a FKBP-family ligand intended for use as the target-engaging component or reference ligand in PROTAC discovery workflows. Its known small-molecule recognition profile enables rational linker-vector evaluation and comparative degrader design. This molecule is described in detail below.
Structure: The structure of SLF is characterized by carboxylic acid or carboxylate handle; primary or secondary amine/basic nitrogen centers; macrocyclic or peptidomimetic scaffold. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.
Reactivity: The acid handle supports amide coupling with amino-PEG, alkyl-diamine, piperazine, or aminoalkyl E3-ligase ligands. For FKBP-directed chemical biology, it may be connected to degradation or dimerization modules through flexible PEG/alkyl or amide-containing linkers, subject to FKBP-binding SAR. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.